Breaking News

Amgen, Patheon Ink Flex Mfg. Pact

March 14, 2016

To provide flexible manufacturing services Amgen's therapeutics

Patheon has signed a manufacturing agreement with Amgen to provide flexible manufacturing services for their therapeutics. Additional details were not disclosed.
“As we launch new products and expand into more countries, it is critical to have the capacity to respond to increases in demand for our medicines,” said Rayne Waller, vice president, global supply chain at Amgen. “Manufacturing remains a core competency and a competitive advantage for Amgen and we are committed to supplying every patient, every time. This arrangement with Patheon supplements our own manufacturing network and provides us flexibility to ensure supply.” 
“We believe the departure from the “build or buy” paradigm represents a superior value for our clients,” said Michael Lehmann, executive vice president, global sales and marketing for Patheon. “These flexible capacity solutions require a strategic and collaborative approach – different from the traditional “price per batch” concept.  This agreement with Amgen is representative of the changing dialogue in the pharmaceutical services industry.”
Patheon provides process development and cGMP manufacturing services for both drug substance and drug product, from preclinical to commercial supply, to its global client base.

Related Contract Manufacturing:

Related Packaging:

  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks